JSPR
Jasper Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.69 / 10
Netural
Fund flow data reveal a good score of 7.3/10, yet overall and block trends are negative, hinting at underlying selling pressure despite the high score. Analyst coverage is minimal with only one active analyst issuing a neutral rating, and historical win rate is 100% but based on a single prediction. This limited analyst input and conflicting fund-flow signals contribute to a neutral sentiment outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-11
InstitutionRBC Capital
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of JSPR?
- JSPR holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.69/10 (Netural).
